-----

Welcome to the March 2014 issue of Pharmaceutical Technology Sourcing and Management, an information resource for contract manufacturing, ingredients sourcing, and the supply chain from the editors of Pharmaceutical Technology and Pharmaceutical Technology Europe. In this issue, discover the top 10 trends in biopharmaceutical manufacturing, API manufacturing demand and supply chain security, and the latest trends in outsourcing, supply chain, and CMO market developments.

Manufacturing Trends
Top 10 Outsourcing Trends in Biopharmaceutical Manufacturing
In biopharmaceutical manufacturing, outsourcing and off-shoring have migrated into much more high-value areas.
>> Read More

API Synthesis and Manufacturing
Demand Increases for Novel Excipients, but Manufacturers Still Face Challenges
Drug formulators are looking for new excipients to address solubility and bioavailability issues and extend patent protection, but there are hurdles to using novel, specialized ingredients.
>> Read More

API Synthesis and Manufacturing
Regulatory Initiatives Spur API Supply Chain Security
In order to ensure a safe drug supply chain, governments have implemented both legislated and voluntary programs designed to address problem areas.
>> Read More

Outsourcing
Alternative Expression Systems May Cut Bioprocessing Costs, Open New CMO Opportunities
Novel expression systems such as plant-based manufacturing platforms are expected to dramatically lower manufacturing costs. How will the market respond with outsourcing options?.
>> Read More

Outsourcing
Local Knowledge Drives Global Market Expansion
Pharma companies entering new regional markets can find expertise in local regulations and business customs through outsourced services.
>> Read More

Outsourcing
Reaching China’s Clinical Trial Market
Geographic location, customs and drug-development regulations knowledge, and transportation infrastructure were factors in Catalent Pharma Solutions’ selection of Shanghai for its clinical-trials supply facility.
>> Read More

Interphex 2014 Preview
The Changing Contract Services Landscape
Special Session at Interphex 2014, Jacob Javits Center, New York City
Wednesday, March 19, 9 am –10 am, Room 1E21
The contract services industry finds itself in a different place than it did one year ago. A favorable financial environment to raise capital, ventures into proprietary products, and more resources for R&D at bio/pharma companies means the contract services landscape is evolving. Hear about the consolidation of the CMO universe, the evolution of new service combinations, and the industry's outlook for the next few years in Jim Miller’s annual CMO market address, sponsored by Pharmaceutical Technology and BioPharm International
Presenter: Jim Miller, president of PharmSource Information Services, Inc., and publisher of Bio/Pharmaceutical Outsourcing Report
>>Session datails
>>Register here

Supply Chain
FDA Initiates Secure Supply Chain Pilot Program
Thirteen companies are accepted for participation in the supply chain program.
>> Read More

Supply Chain
Ranbaxy Suspends API Shipments from Two Plants in India
Daiichi Sankyo announced suspension of API shipments from Ranbaxy's Toansa and Dewas plants and issued an apology to stakeholders.
>> Read More

Corporate Social Responsibility
Inflammatory Diseases Explained in Artistic Designs
AbbVie launches art initiative designed to explore impact of chronic inflammatory diseases.
>> Read More

Corporate Social Responsibility
MedImmune Announces Research Collaboration with UC San Francisco
MedImmune and AstraZeneca enter a three-year collaboration with the Clinical and Translational Science Institute at the UC San Francisco.
>> Read More

Corporate Social Responsibility
Lilly Diabetes Donates 91 Scholarships to American Diabetes Association's Summer Camp Program
Lilly Diabetes supports the American Diabetes Association for the seventh year in a row.
>> Read More

Business News Roundup

Almac Adds New Blistering Technology

Metrics Expands with Fast-Track Development Laboratory

GMP Certification Extended for Cobra Biologics

AbbVie Expands Manufacturing Presence in Singapore

Croda Receives Two EXCiPACT Certifications

Events

DCAT Week 2014:
March 10-13, 2014, New York, NY

BIO-Europe Spring 2014:
March 10-12, 2014, Turin, Italy

INTERPHEX 2014:
March 18-20, 2014, New York, NY

Webcasts

Strategies for Successful Scale-up Using Quality by Design
March 27, 2:00 to 3:00 PM Eastern US Time
Sponsored by DPT and Confab

Navigating the Analytical Development Challenges for Bioprocess Residuals and Impurities
April 1, 2014 at 1:00 PM EDT and April 3, 2014 at 15:00 CET
Sponsored by Eurofins Lancaster Laboratories

Overcoming Challenges in the Development of Active Drug-Layered Formulations for Multiple Dosage Forms
April 8, 2014 at 11:00 AM EDT
Sponsored by Patheon